Skip to main content
Equibles

MDXH · MDxHealth SA

Track MDXH — free

Use MDXH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDXH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.61 +0.01 (+2.23%)
Rebalance outlook locked
Market Cap
$53.93M
Shares
95.42M
Volume · Oct 5 126.2K Avg daily vol (3M) 5.62M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.60 Open$0.57 Day$0.56–0.61 52W close$0.40–5.00 Avg vol 30d230K Short int1.5M · 1.6% float · 7.8d Short vol45% Last earningsNov 12, 2026 DataNov 2021–Oct 2026

Up next

Next earnings call
Nov 12, 2026 Scheduled · in 5 wks
Q1 2026 earnings call transcript
call held Mar 31, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+19.8%
Year over year
Operating margin
-13.4%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.8%
Year over year · more shares
Price change (1Y)
-88.1%
Trailing year
Short interest
1.6%
Latest settlement · 7.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −67%
below
Price vs 50-day avg −2%
below
RSI (14) 47
neutral
MACD trend Negative
52-week position 4%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −20%
trailing
6-month return −74%
trailing
YTD return −83%
this year
Relative strength −85%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Distributing
-50% holders QoQ · +5 funds added
Insider flow Accumulating
Net +$1000.0K over 90 days · 0% sells
Short interest Falling
1.59% of float · ▼ -1.1% MoM · 7.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
26 holders — mid 2-yr range
Squeeze score 49
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 113%
annualized · 1-yr
Max drawdown −92%
past year
ATR 8.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−67% Bearish
Price vs 50-day avg
−2% Neutral
RSI (14)
47 Neutral
MACD trend
Negative Bearish
52-week position
4% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Distributing
-50% holders QoQ · +5 funds added
Insider flow Accumulating
Net +$1000.0K over 90 days · 0% sells
Short interest Falling
1.59% of float · ▼ -1.1% MoM · 7.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
26 holders — mid 2-yr range
Price context
position in its 52-week range
Range low $0 Now $1 · 4% Range high $5
vs 200-day avg -67% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Diagnostics & Research — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MDXH
MDxHealth SA
this stock
$53.93M -83.3% — — 1.6%
TMO
Thermo Fisher Scientific Inc.
 $249.58B +16.8% +14.5% 36.3 1.4%
DHR
Danaher Corp /De/
 $150.37B -3.4% +8.5% 37.9 1.2%
NTRA
Natera, Inc.
 $59.47B +85.8% -2.8% — 3.3%
A
Agilent Technologies, Inc.
 $48.90B +25.9% +6.4% 34.2 1.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
26
% held
17.4%
Net QoQ
-132.5M sh
Top holder
Bleichroeder LP
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
1.5M
Days to cover
7.8d
Change
-17.4K sh
View
Short Volume
Short vol %
45%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
421
Value
$295
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
54.5%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$1000.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 3, 2026
This year
11
View
Proposed Sales
Value
$1.1M
Shares
1.5M
Filed
Sep 17, 2026
View
Exempt Offerings
Offering
Indefinite
Filed
Aug 15, 2022
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 12, 2026
Last webcast
Aug 13, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
MDXH +8.9% -20.2% -73.7% +2.1% -83.3%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY +7.7% -20.8% -85.3% +0.5% -96.9%
Key facts CIK 1872529 CUSIP B5950S113 Visit website Investor relations